Regencell Bioscience Financials - Benzinga

Regencell Bioscience Holdings Ltd

RGCNASDAQ

Trade with Public

Trade with Public

$5.48

0.193.59%

al cierre: Aug 25, 5:00 PM EST

Panorámica general Noticias Previsión de beneficiosFinanzasSentimiento Propiedad Comparar Opciones Informe de acciones

Regencell Bioscience Financials

Regencell Bioscience (RGC) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Top Stocks With Earnings This Week: Nvidia, PDD And More

Here's a look at the most-watched earnings reports for this week including Nvidia, PDD, Walmart, Palo Alto and more.

Erica Kollmann

GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

PRO
Regencell Bioscience H1 EPS $(0.36) Up From $(0.42) YoY

Regencell Bioscience (NASDAQ:RGC) reported quarterly losses of $(0.36) per share. This is a 14.29 percent increase over losses of $(0.42) per share from the same period last year.

Benzinga Newsdesk

Dow Surges Over 100 Points; Accenture Posts Upbeat Earnings

Avi Kapoor

US Stocks Higher; Dow Jumps Over 400 Points

Avi Kapoor

Deere Posts Upbeat Earnings, Joins Foot Locker, Boot Barn, Cisco And Other Big Stocks Moving Higher On Thursday

Avi Kapoor

© 2026 Benzinga | All Rights Reserved